{"id":7513,"date":"2025-05-08T13:06:00","date_gmt":"2025-05-08T11:06:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/"},"modified":"2025-05-08T13:06:00","modified_gmt":"2025-05-08T11:06:00","slug":"nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/","title":{"rendered":"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni"},"content":{"rendered":"
\n

Nanexa meddelar att resultaten fr\u00e5n den nyligen slutf\u00f6rda fas I-studien med NEX-22 har blivit godk\u00e4nda som ett Late Breaking Abstract p\u00e5 den prestigefyllda ADA-kongressen (American Diabetes Association) som h\u00e5lls i Chicago 20-23 juni. <\/strong><\/p>\n<\/div>\n

\n

Abstraktet presenterar resultat fr\u00e5n fas I-studien med NEX-22, som tagits fram i samarbete med det inom diabetesforskning v\u00e4lrenommerade CROt Profil i Tyskland.
NEX-22 \u00e4r Nanexas PharmaShell-baserade enm\u00e5nadsdep\u00e5 av GLP-1 substansen liraglutid, avsedd f\u00f6r behandling av typ 2-diabetes. Liraglutid ges idag som en daglig injektion. NEX-22 f\u00f6rv\u00e4ntas f\u00f6renkla behandlingen och d\u00e4rigenom \u00f6ka f\u00f6ljsamheten.<\/p>\n

\u201dDetta \u00e4r ett erk\u00e4nnande av v\u00e5ra intressanta data med NEX-22\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa. \u201dVi ser fram emot b\u00e5de vetenskapliga diskussioner och m\u00f6jligheten att m\u00f6ta f\u00f6retag inom branschen. Detta \u00e4r ett v\u00e4lkommet bidrag till v\u00e5r aff\u00e4rsutveckling och st\u00e4rker v\u00e5r position inom diabetesforskning och behandling.\u201d<\/p>\n

Abstraktet har valts ut f\u00f6r posterpresentationen under kongressen och kommer \u00e4ven att publiceras p\u00e5 tidskriften Diabetes\u00ae webbplats i juni.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Bolagets Certified Adviser \u00e4r Carnegie Investment Bank AB (publ).<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa meddelar att resultaten fr\u00e5n den nyligen slutf\u00f6rda fas I-studien med NEX-22 har blivit godk\u00e4nda som ett Late Breaking Abstract p\u00e5 den prestigefyllda ADA-kongressen (American Diabetes Association) som h\u00e5lls i Chicago 20-23 juni.<\/p>\n","protected":false},"template":"","class_list":["post-7513","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-ext-nq_sv","mfn-news-tag-mfn-ext-nq-company-announcement_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa meddelar att resultaten fr\u00e5n den nyligen slutf\u00f6rda fas I-studien med NEX-22 har blivit godk\u00e4nda som ett Late Breaking Abstract p\u00e5 den prestigefyllda ADA-kongressen (American Diabetes Association) som h\u00e5lls i Chicago 20-23 juni.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\\\/\",\"name\":\"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2025-05-08T11:06:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB","og_description":"Nanexa meddelar att resultaten fr\u00e5n den nyligen slutf\u00f6rda fas I-studien med NEX-22 har blivit godk\u00e4nda som ett Late Breaking Abstract p\u00e5 den prestigefyllda ADA-kongressen (American Diabetes Association) som h\u00e5lls i Chicago 20-23 juni.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/","name":"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2025-05-08T11:06:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-far-late-breaking-abstract-godkant-till-ada-kongressen-i-chicago-i-juni\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa f\u00e5r Late Breaking Abstract godk\u00e4nt till ADA-kongressen i Chicago i juni"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}